Navidea Biopharmaceuticals Inc (NAVB)
0.0375
0.00 (0.00%)
USD |
OTCM |
Apr 24, 16:00
Navidea Biopharmaceuticals Total Liabilities (Quarterly): 8.679M for Sept. 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | 8.679M |
June 30, 2023 | 9.006M |
March 31, 2023 | 11.92M |
December 31, 2022 | 12.51M |
September 30, 2022 | 10.93M |
June 30, 2022 | 6.744M |
March 31, 2022 | 5.712M |
December 31, 2021 | 6.020M |
September 30, 2021 | 4.826M |
June 30, 2021 | 4.845M |
March 31, 2021 | 5.068M |
December 31, 2020 | 5.711M |
September 30, 2020 | 5.095M |
June 30, 2020 | 8.729M |
March 31, 2020 | 5.568M |
December 31, 2019 | 5.032M |
September 30, 2019 | 4.914M |
June 30, 2019 | 5.199M |
March 31, 2019 | 4.865M |
December 31, 2018 | 4.611M |
September 30, 2018 | 7.099M |
June 30, 2018 | 5.874M |
March 31, 2018 | 13.37M |
December 31, 2017 | 8.733M |
September 30, 2017 | 6.590M |
Date | Value |
---|---|
June 30, 2017 | 8.561M |
March 31, 2017 | 10.56M |
December 31, 2016 | 80.13M |
September 30, 2016 | 74.96M |
June 30, 2016 | 72.59M |
March 31, 2016 | 69.44M |
December 31, 2015 | 68.80M |
September 30, 2015 | 69.30M |
June 30, 2015 | 66.82M |
March 31, 2015 | 46.28M |
December 31, 2014 | 41.63M |
September 30, 2014 | 48.90M |
June 30, 2014 | 47.42M |
March 31, 2014 | 47.25M |
December 31, 2013 | 44.33M |
September 30, 2013 | 41.07M |
June 30, 2013 | 32.95M |
March 31, 2013 | 16.32M |
December 31, 2012 | 13.38M |
September 30, 2012 | 10.85M |
June 30, 2012 | 10.09M |
March 31, 2012 | 10.02M |
December 31, 2011 | 10.06M |
September 30, 2011 | 4.894M |
June 30, 2011 | 5.910M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.826M
Minimum
Sep 2021
12.51M
Maximum
Dec 2022
7.028M
Average
5.711M
Median
Total Liabilities (Quarterly) Benchmarks
Perspective Therapeutics Inc | 22.71M |
Electromed Inc | 6.622M |
Xtant Medical Holdings Inc | 41.26M |
Asensus Surgical Inc | 25.67M |
Senseonics Holdings Inc | 102.42M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 5.699M |
Shareholders Equity (Quarterly) | -3.273M |